Dr. Lawrence Paul Bruno, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 19250 Bagley Rd, Suite 105, Middleburg Heights, OH 44130 Phone: 440-826-0770 Fax: 440-826-0775 |
Daniel Kana, D.O. Orthopaedic Surgery - Sports Medicine Medicare: Medicare Enrolled Practice Location: 15299 Bagley Rd Ste 100, Middleburg Heights, OH 44130 Phone: 440-885-2100 |
Dr. Mark Anthony Panigutti, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7255 Old Oak Blvd, C405, Middleburg Heights, OH 44130 Phone: 440-816-5380 Fax: 440-816-5398 |
Dr. Michael Alan Banks, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7255 Old Oak Blvd, Middleburg Heights, OH 44130 Phone: 440-816-5380 Fax: 440-816-5398 |
Dr. Robert M Coale, M.D. Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 7255 Old Oak Blvd, C405, Orthowest, Middleburg Heights, OH 44130 Phone: 440-816-5380 Fax: 440-816-5398 |
News Archive
The after effects of the terror attacks on 11th September 2001 in the United States are still appearing. Around 15 men who were present near the Ground Zero on the fateful day have been diagnosed with rare forms of male breast cancer. Male breast cancer makes up for less than 1 percent of all breast cancers.Â
In advance of the 41st Union World Conference, the Global Alliance for TB Drug Development (TB Alliance) today announced the launch of the first clinical trial to test a novel tuberculosis regimen in a new development paradigm designed to speed new treatments to patients. This novel three-drug combination shows promise to treat both drug-sensitive (DS-TB) and multidrug-resistant TB (MDR-TB), and alter the course of the TB pandemic by shortening and simplifying treatment worldwide.
Jennerex, Inc., a private, clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic immunotherapies, today announced that the first patient has been treated in a Phase 2 clinical trial of intravenous treatment with JX-594 for patients with advanced hepatocellular carcinoma (HCC), or liver cancer, who have not received treatment with sorafenib—the current standard of care for this patient population.
Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have produced new evidence that brain circuits involved in drug addiction are also activated by the desire for food.
On May 20, 2015, the U.S. Food and Drug Administration (FDA) cleared Nova Biomedical's StatStrip Xpress Glucose Hospital Meter System for use throughout all hospital and all professional healthcare settings, including critically ill patients.
› Verified 7 days ago